Innoviva (INVA) Stock Forecast & Price Target

INVA$18.83-0.25 -1.33%
BiotechnologyValue StockGrowth StockHigh Quality
Compare
Market cap$1.34BEnterprise value$1.06BRevenue (TTM)$441.75MMarket position—

Score

70
Bullish
Value
72
Quality
71
Growth
67

Innoviva, Inc. price target

INVA
Low$34.00
Average$34.00
High$34.00
Upside vs current price+80.6%

The average target of $34.00 is +80.6% versus the current INVA price of $18.83.

Innoviva, Inc. analyst ratings

RatingAnalysts
Strong buy0
Buy4
Hold0
Sell1
Strong sell0
ConsensusBuy

5 analysts cover INVA.

Innoviva, Inc. EPS and revenue estimates

Published annual figures for INVA on this page are 2026 EPS $1.79, 2027 EPS $2.25. Coverage under three analysts is omitted.

Fiscal yearEPS estimateRevenue estimate
2026$1.79$450.26M
2027$2.25$491.44M

Is Innoviva, Inc. a buy or sell?

Of the 5 analysts covering Innoviva, Inc., 4 rate it a buy (0 strong buy and 4 buy), 0 rate it a hold, and 1 rates it a sell (1 sell and 0 strong sell).

The INVA consensus label is Buy, beside 4 buy-side ratings and 1 sell-side ratings.

The average target of $34.00 implies +80.6% versus the current price of $18.83.

The INVA rating block is 5 published views with a Buy label. It does not tell you whether to buy or sell.

Reading the Innoviva, Inc. forecast

the Innoviva, Inc. has a tight target cluster: $34.00 to $34.00, average $34.00.

The gap from the $18.83 price to the INVA average is +80.6%.

The INVA rating mix is lopsided rather than split: 4 of 5 analysts are on the buy side, 0 are at hold, and 1 is on the sell side, and the published consensus is Buy.

the Innoviva, Inc. has a rising EPS path, $1.79 for 2026 and $2.25 for 2027.

With 5 analysts on INVA, the average is a small sample.

Innoviva, Inc. forecast questions

What is the INVA price target?

The published range for INVA is $34.00 to $34.00, with an average of $34.00. That average is +80.6% versus the current price of $18.83.

Is Innoviva, Inc. a buy or sell?

Of the 5 analysts covering Innoviva, Inc., 4 rate it a buy, 0 rate it a hold, and 1 rates it a sell. The consensus is Buy, leaving INVA at 4 buy ratings, 0 holds, and 1 sells.

What is the EPS estimate for Innoviva, Inc.?

Analyst EPS estimates for Innoviva, Inc.: 2026 $1.79, 2027 $2.25.

What is the revenue estimate for Innoviva, Inc.?

Analyst revenue estimates for Innoviva, Inc.: 2026 $450.26M, 2027 $491.44M.

How many analysts cover INVA?

5 analysts cover INVA. Their consensus on INVA is Buy, across those 5.

INVA price $18.83 -0.25 -1.33%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener